PharmEasy to acquire 66.1 percent stake in Thyrocare for Rs 4546 crore
Chennai: API Holdings, the parent company of digital healthcare brand, PharmEasy, announced on Friday that it has entered into a definitive agreement, acquiring a 66.1 percent stake in Thyrocare from Dr. A Velumani and affiliates for Rs 1,300 per share, totaling Rs 4,546 crores.
This is happened when the dynamic 32-year-old Siddharth Shah, Co-founder & CEO of API Holdings, met with 62-year-old, diagnostic services veteran Dr. A Velumani, Chairman of Thyrocare in monsoon drenched Lonavala over masala chai at the Thyrocare Chairman's residence and a landmark deal was struck in record time.
Through a recent release, PharmEasy, founded by Dharmil Sheth, Dhaval Shah, Harsh Parekh, Hardik Dedhiaand Siddharth Shah, has announced the signing of definitive documents to acquire 66.1% stake in Thyrocare Technologies Ltd (Thyrocare) from Dr. A Velumani and affiliates at a price of INR 1,300 per share aggregating to INR 4,546 crs.
Dr. A Velumani will be separately acquiring a minority non-controlling stake, of less than 5% in API as part of a series of equity investments by existing and new investors of API, the release stated.
The collaboration between PharmEasy and Thyrocare is unique and transformative for the Indian healthcare sector, consumers and the entire healthcare ecosystem. The synergies of both, India's largest digital health platform and one of the largest, cost-effective diagnostics solution providers (by volume) will reimagine and accelerate the delivery of high-quality diagnostic and OPD services across the full continuum of patient care to nearly 800mn Indians.
As per the statement, PharmEasy's strong belief and commitment is to provide an integrated digital health platform which enables in democratizing quality healthcare to all Indians, and the company will leverage its deep technology expertise across every single part of the OPD value chain to achieve availability, affordability and accessibility for consumers.
On the addition of Thyrocare into its portfolio, Mr Siddharth Shah, CEO, API Holdings commented "We are delighted to be partnering Thyrocare. We will provide world class customer experience in diagnostics, rivalling our pharmacy experience by leveraging technology, and building on top of the massive scale & truly pan-India presence of Thyrocare. It is our aim to deliver all outpatient healthcare products & services to every Indian within 24 hours."
Meanwhile, Dr A. Velumani, Chairman & MD of Thyrocare, expressed "I am excited about this relationship, unique of its kind in Indian Healthcare Industry. The unique reach and strength of Thyrocare in Diagnostics blended with young and dynamicteam of PharmEasy will bring in better healthcare solutions for common man nationwide."
Next Story
